Toxicity associated with intravesical cisplatinum in a patient with superficial bladder cancer.
Anaphylactic reactions to cisplatinum chemotherapy are infrequent. The second case of such a response in a man treated with intravesical cisplatinum for superficial transitional cell carcinoma of the bladder is presented.